FOXC1, the New Player in the Cancer Sandbox

Overview

Journal Oncotarget

Specialty Oncology

Date 2018 Mar 1

PMID 29487724

Citations 29

Authors

Fahed A Elian

Elizabeth Yan

Michael A Walter

Affiliations

Soon will be listed here.

Abstract

In recent years, rapidly accumulating evidence implicates forkhead box C1 () in cancer, especially in studies of basal-like breast cancer (BLBC). Other studies have followed suit, demonstrating that is not only a major player in this breast cancer subtype, but also in hepatocellular carcinoma (HCC), endometrial cancer, Hodgkin's lymphoma (HL), and non-Hodgkin's lymphoma (NHL). The gene encodes a transcription factor that is crucial to mesodermal, neural crest, and ocular development, and mutations found in have been found to cause dominantly inherited Axenfeld-Rieger Syndrome (ARS). Interestingly, while missense mutations that are associated with ARS usually reduce gene activity, increased function now appears to be often linked to more aggressive cancer phenotypes in BLBC, HCC, HL, and NHL. This review discusses not only the role of in cancer cell progression, proliferation, differentiation, and metastasis, but also the underlying mechanisms of how can contribute to aggressive cancer phenotypes.

Citing Articles

Diagnostic Challenges of Axenfeld-Rieger Syndrome and a Novel FOXC1 Gene Mutation in a Polish Family.

Wowra B, Wysocka-Kosmulska M, Stanienda-Sokol K, Lach-Wojnarowicz O, Dobrowolski D, Wylegala E J Clin Med. 2024; 13(19).

PMID: 39407821 PMC: 11477508. DOI: 10.3390/jcm13195761.

Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection.

Raj-Kumar P, Lin X, Liu T, Sturtz L, Gritsenko M, Petyuk V Breast Cancer Res. 2024; 26(1):76.

PMID: 38745208 PMC: 11094977. DOI: 10.1186/s13058-024-01835-4.

Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression.

Zhang F, Xu Y, Lin J, Pan H, Giuliano A, Cui X Breast Cancer Res Treat. 2024; 204(3):465-474.

PMID: 38183514 PMC: 10959774. DOI: 10.1007/s10549-023-07177-7.

Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer.

Tuly K, Hossen M, Islam M, Kibria M, Alam M, Harun-Or-Roshid M Medicina (Kaunas). 2023; 59(10).

PMID: 37893423 PMC: 10608013. DOI: 10.3390/medicina59101705.

Role of Fork-Head Box Genes in Breast Cancer: From Drug Resistance to Therapeutic Targets.

Sadaf , Hazazi A, Alkhalil S, Alsaiari A, Gharib A, Alhuthali H Biomedicines. 2023; 11(8).

PMID: 37626655 PMC: 10452497. DOI: 10.3390/biomedicines11082159.

References

Qian B, Li J, Zhang H, Kitamura T, Zhang J, Campion L . CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011; 475(7355):222-5. PMC: 3208506. DOI: 10.1038/nature10138. View

Zweidler-McKay P, He Y, Xu L, Rodriguez C, Karnell F, Carpenter A . Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood. 2005; 106(12):3898-906. PMC: 1895093. DOI: 10.1182/blood-2005-01-0355. View

Semenza G . Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-32. DOI: 10.1038/nrc1187. View

Hara H, Wada T, Bakal C, Kozieradzki I, Suzuki S, Suzuki N . The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity. 2003; 18(6):763-75. DOI: 10.1016/s1074-7613(03)00148-1. View

Eichenauer D, Aleman B, Andre M, Federico M, Hutchings M, Illidge T . Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018; 29(Suppl 4):iv19-iv29. DOI: 10.1093/annonc/mdy080. View

Conway E, Collen D, Carmeliet P . Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001; 49(3):507-21. DOI: 10.1016/s0008-6363(00)00281-9. View

Forsythe J, Jiang B, Iyer N, Agani F, Leung S, Koos R . Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996; 16(9):4604-13. PMC: 231459. DOI: 10.1128/MCB.16.9.4604. View

Bokhman J . Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983; 15(1):10-7. DOI: 10.1016/0090-8258(83)90111-7. View

Mani S, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N . Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A. 2007; 104(24):10069-74. PMC: 1891217. DOI: 10.1073/pnas.0703900104. View

10.

Bessette D, Qiu D, Pallen C . PRL PTPs: mediators and markers of cancer progression. Cancer Metastasis Rev. 2008; 27(2):231-52. DOI: 10.1007/s10555-008-9121-3. View

11.

LUKES R, Butler J . The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966; 26(6):1063-83. View

12.

Egawa T, Albrecht B, Favier B, Sunshine M, Mirchandani K, OBrien W . Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation. Curr Biol. 2003; 13(14):1252-8. DOI: 10.1016/s0960-9822(03)00491-3. View

13.

Pugh C, Ratcliffe P . Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003; 9(6):677-84. DOI: 10.1038/nm0603-677. View

14.

Hong H, Lass J, Chakravarti A . Pleiotropic skeletal and ocular phenotypes of the mouse mutation congenital hydrocephalus (ch/Mf1) arise from a winged helix/forkhead transcriptionfactor gene. Hum Mol Genet. 1999; 8(4):625-37. DOI: 10.1093/hmg/8.4.625. View

15.

Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z . Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13(1):9-22. View

16.

Pradella D, Naro C, Sette C, Ghigna C . EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression. Mol Cancer. 2017; 16(1):8. PMC: 5282733. DOI: 10.1186/s12943-016-0579-2. View

17.

Yao X, Qi L, Chen X, Du J, Zhang Z, Liu S . Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma. Urol Oncol. 2013; 32(2):162-70. DOI: 10.1016/j.urolonc.2012.12.006. View

18.

Hayden M, Ghosh S . NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012; 26(3):203-34. PMC: 3278889. DOI: 10.1101/gad.183434.111. View

19.

Paik J, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z . FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 2007; 128(2):309-23. PMC: 1855089. DOI: 10.1016/j.cell.2006.12.029. View

20.

Li Z, Cao Y, Jie Z, Liu Y, Li Y, Li J . miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Lett. 2012; 323(1):41-47. DOI: 10.1016/j.canlet.2012.03.029. View